LYELLyell Immunopharma, Inc.

Nasdaq lyell.com


$ 1.40 $ 0.18 (15.16 %)    

Tuesday, 17-Sep-2024 15:31:40 EDT
QQQ $ 472.49 $ -3.48 (-0.73 %)
DIA $ 416.51 $ -1.48 (-0.35 %)
SPY $ 561.85 $ -3.28 (-0.58 %)
TLT $ 100.95 $ -0.44 (-0.43 %)
GLD $ 237.24 $ -0.74 (-0.31 %)
$ 1.24
$ 1.22
$ 1.39 x 166
$ 1.40 x 227
$ 1.21 - $ 1.40
$ 1.09 - $ 3.26
508,952
na
317.44M
$ 1.27
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2024 06-30-2024 10-Q
2 05-06-2024 03-31-2024 10-Q
3 02-28-2024 12-31-2023 10-K
4 11-07-2023 09-30-2023 10-Q
5 08-08-2023 06-30-2023 10-Q
6 05-04-2023 03-31-2023 10-Q
7 02-28-2023 12-31-2022 10-K
8 11-08-2022 09-30-2022 10-Q
9 08-04-2022 06-30-2022 10-Q
10 05-10-2022 03-31-2022 10-Q
11 03-29-2022 12-31-2021 10-K
12 11-12-2021 09-30-2021 10-Q
13 08-12-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-neutral-on-lyell-immunopharma-maintains-1-price-target

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Lyell Immunopharma (NASDAQ:LYEL) with a Neutral and maintains $1 ...

 lyell-immunopharma-q2-adj-018-beats-020-estimate-sales-1300k-down-from-2700k-yoy

Lyell Immunopharma (NASDAQ:LYEL) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(...

 b-of-a-securities-maintains-buy-on-lyell-immunopharma-lowers-price-target-to-6

B of A Securities analyst Geoff Meacham maintains Lyell Immunopharma (NASDAQ:LYEL) with a Buy and lowers the price target fr...

 hc-wainwright--co-downgrades-lyell-immunopharma-to-neutral-lowers-price-target-to-1

HC Wainwright & Co. analyst Mitchell Kapoor downgrades Lyell Immunopharma (NASDAQ:LYEL) from Buy to Neutral and lowers t...

 lyell-immunopharma-shares-plunge-on-one-patient-death-in-car-t-cell-therapy-cancer-trial

Lyell Immunopharma shares fell following the release of initial clinical data from its Phase 1 trial of LYL797, a reprogrammed ...

 lyell-immunopharma-announced-initial-clinical-and-translational-data-from-its-phase-1-trial-of-lyl797-its-first-generation-reprogrammed-ror1-car-tcell-product-candidate-for-blood-cancers

Dose-dependent antitumor clinical activity in ROR1+ relapsed/refractory triple-negative breast cancer; 40% objective response...

 hc-wainwright--co-reiterates-buy-on-lyell-immunopharma-maintains-6-price-target

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Lyell Immunopharma (NASDAQ:LYEL) with a Buy and maintains $6 pric...

 lyell-immunopharma-q1-sales-3000k-down-from-65000k-yoy

Lyell Immunopharma (NASDAQ:LYEL) reported $3.000 thousand in sales this quarter. This is a 95.38 percent decrease over sales of...

 live-nation-entertainment-groupon-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session

U.S. stock futures were mixed this morning, with the Dow futures gaining around 100 points on Tuesday.

 why-jpmorgan-shares-are-trading-lower-by-around-5-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings.

 argan-reports-upbeat-earnings-joins-coupang-and-other-big-stocks-moving-higher-on-friday

U.S. stocks were lower, with the Dow Jones index falling over 250 points on Friday. Shares of Argan, Inc. (NYSE: AGX) rose sh...

 why-tilray-brands-shares-are-trading-lower-by-around-22-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Tilray Brands, Inc. (NASDAQ: TLRY) fell sharply during Tuesday’s session after the company missed third-quarter esti...

 blackberry-nurix-therapeutics-tesla-and-other-big-stocks-moving-higher-on-tuesday

U.S. stocks were lower, with the Dow Jones index falling over 200 points on Tuesday. Shares of BlackBerry Limited (NYSE: BB) ...

 tesla-spirit-airlines-new-york-community-bancorp-and-other-big-stocks-moving-lower-on-monday

U.S. stocks were lower, with the Dow Jones index falling around 80 points on Monday.

 on-wednesday-february-28-2024-lyell-immunopharma-reported-q4-adjusted-eps-017-beats-023-estimate-sales-1300k-down-from-4839m-yoy

Lyell Immunopharma (NASDAQ:LYEL) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(...

 hc-wainwright--co-maintains-buy-on-lyell-immunopharma-lowers-price-target-to-6

HC Wainwright & Co. analyst Mitchell Kapoor maintains Lyell Immunopharma (NASDAQ:LYEL) with a Buy and lowers the price t...

 why-longboard-pharmaceuticals-shares-are-trading-higher-by-around-200-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Longboard Pharmaceuticals, Inc.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION